Company Filing History:
Years Active: 2025
Title: Thomas Peter John Dunkley: Innovator in UBE3A Protein Targets
Introduction
Thomas Peter John Dunkley is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of protein targets. His work focuses on the UBE3A protein, which plays a crucial role in various biological processes.
Latest Patents
Dunkley holds a patent related to E3 ubiquitin ligase (UBE3A) protein targets. The invention pertains to UBE3A protein targets and their usage as target engagement biomarkers for compounds that modulate UBE3A expression. This innovation has the potential to impact therapeutic strategies for conditions associated with UBE3A dysregulation.
Career Highlights
Dunkley is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves research and development in the field of biotechnology, where he applies his expertise to advance scientific knowledge and innovation.
Collaborations
Throughout his career, Dunkley has collaborated with talented professionals, including Veronica Costa and Nikhil Janak Pandya. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Thomas Peter John Dunkley is a distinguished inventor whose work on UBE3A protein targets exemplifies the intersection of science and innovation. His contributions continue to influence the field of biotechnology and hold promise for future advancements.